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A Case of TB-Induced Hypersensitivity
Shira Amdur, MD; Charles Pizanis, MD
Albuquerque, NM

Background
Erythema induratum (EI), also referred to as Erythema induratum of
Bazin or nodular vasculitis, describes the most common variant of lobular
panniculitis initially described by Bazin in 1861. Around 1900, the link
between EI was noted and EI was then classified as a tuberculid. More
recently, EI was reconsidered as a hypersensitivity reaction often, but not
exclusively, associated with Mycobacterium tuberculosis infection.
EI presents clinically as painful, recurrent violaceous nodules and plaques
on the lower extremities that then leave a scar hyperpigmentation. It can
closely resemble erythema nodosum and is distinguished
histopathologically.

Lobular panniculitis

Necrotizing vasculitis; caseating necrosis

Case Presentation
A 53-year-old man who immigrated to the United States from Vietnam
approximately 1 year prior presented to his primary care physician with a
rash on his lower legs. He described a 1-month history of painful, red
bumps initially on his calves, which spread anteriorly. He rated the pain
9/10 and complained that it kept him up at night. Ibuprofen provided
some relief and oxycodone provided no relief. He was given a course of
Keflex but his rash did not respond. He also complained of fevers, chills,
fatigue, joint pain and swelling (ankles, MCPs, and PIPs). He denied
cough, hemoptysis or night sweats. He also denied recent travel or sick
contacts, including known exposure to anyone with tuberculosis. The
patient was referred to Rheumatology at which time he was considered to
have erythema nodosum and hydroxychloroquine was prescribed. Several
labs were ordered including a QuantiFERON Gold, which came back
reactive. Other abnormal labs included elevated ESR, CRP, C4, and a
differential significant for an eosinophilia. A prior chest x-ray was
negative. Patient was referred to the Department of Health for latent
tuberculosis, as well as to Dermatology for skin biopsy. Biopsy was
undertaken and showed septal and lobular panniculitis with
granulomatous inflammation, fat necrosis, caseating necrosis, and
vascular damage (a deep dermal vessel had fibrinoid necrosis), all
consistent with EI. As a result, the patient was advised to stop taking the
hydroxychloroquine and was counseled on the importance of compliance
with his anti-tuberculosis regimen. Following this, the patient was treated
for latent TB, and his EI significantly improved.

Treatment
Necrotizing vasculitis; caseating necrosis

Inflammatory infiltrate of fat lobule; mostly
neutrophil presence

It is essential to treat the underlying cause. In the case of association with
tuberculosis, evidence supports treating with “RIPE” for 8 weeks initially,
followed by maintenance treatment with rifampin and isoniazid for 14
weeks (assuming low levels of isoniazid resistance). In addition to
association with TB, EI has been associated with HCV, HBV, CLL,
hypothyroidism.

Discussion
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This case illustrates a fascinating example of a cutaneous reaction to M.
tuberculosis. Although this patient did not display any classical
symptoms associated with TB—he had no pulmonary involvement—his
underlying illness was revealed by a QuantiFERON Gold prior to
starting strong immunosuppressants. Erythema induratum is easily
misidentified as erythema nodosum, and the biopsy is crucial in
distinguishing the two. As treatment differs for these two types of
panniculitis, it is critical to correctly identify the condition.
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